Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma

Table 1

Baseline characteristics of HCC patients with and without paraneoplastic syndromes (PNS).

Variable	HCC patients with PNS (𝑛=127)	HCC patients without PNS (𝑛=330)	𝑃
Age	58.3±13.5	60.8±13.3	NS
Male sex	110 (86.6%)	280 (84.8%)	NS
Chinese race	112 (88.2%)	298 (90.3%)	NS
HBsAg positive	82 (64.6%)	197 (59.7%)	NS
Anti-HCV positive	6 (4.7%)	32 (9.7%)	NS
Significant alcohol intake	38 (29.9%)	97 (29.4%)	NS
Child-Pugh A/B/C	57/53/17; (44.9%/41.7%/13.4%)	146/135/49; (44.2%/40.9%/14.8%)	NS
Albumin, G/L	33.8±6.3	32.7±6.0	NS
Bilirubin, 𝜇mol/L	43.4±48.1	40.4±45.6	NS
Prothrombin time, seconds	13.8±2.0	14.2±3.0	NS
Alanine transferase, U/L	62.9±45.8	69.0±100.5	NS
Aspartate transferase, U/L	137.6±118.6	125.9±251.2	NS

Data presented as 𝑛 (%) or mean ± SD.